Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | GSK3B | P49841 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | TNF | P01375 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838583 | 1.00 | IDO1 (1.00) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL25366253 | 1.00 | IDO1 (1.00) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL17867048 | 0.87 | IDO1 (0.76) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL12809540 | 0.87 | IDO1 (0.76) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL14595068 | 0.87 | IDO1 (0.76) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL2042419 | 0.87 | IDO1 (0.76) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL13399673 | 0.87 | IDO1 (0.76) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL28884409 | 0.86 | IDO1 (0.75) | IDO1MAPTTP53GLACYP3A4 | |
| SCHEMBL838519 | 0.86 | IDO1 (0.75) | IDO1MAPTTP53GLACYP3A4 | |
| Potassium SCHEMBL837807 | 0.84 | IDO1 (0.73) | IDO1MAPTTP53GLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287457-A1 | COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-08-29 | — | — | US | disclosed |
| EP-4046635-A9 | COMPOSITION, COMPRISING RIP KINASE INHIBITOR, FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH | Epi Biotech Co., Ltd. (KR) | 2023-10-11 | — | — | EP | disclosed |
| US-20230241031-A1 | Composition, Comprising Rip Kinase Inhibitor, For Preventing Hair Loss Or Promoting Hair Regrowth | EPI BIOTECH CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| EP-4046635-A1 | COMPOSITION, COMPRISING RIP KINASE INHIBITOR, FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH | Epi Biotech Co., Ltd. (KR) | 2022-08-24 | — | — | EP | disclosed |
| CN-114585383-A | Composition for preventing hair loss or promoting hair growth comprising RIP kinase inhibitor | 艾弼生物科技有限公司 | 2022-06-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287457-A1 | COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN | MMP8, NCF1, ELANE | IDO1 2765/4885MAPT 2778/4885TP53 1662/4885 |
| US-20230241031-A1 | Composition, Comprising Rip Kinase Inhibitor, For Preventing Hair Loss Or Promoting Hair Regrowth | RIPK1, RIPK2, RIPK4 | IDO1 1517/4885MAPT 3266/4885TP53 2123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.